Agilent Technologies, Inc. (NYSE:A) Shares Sold by B. Riley Wealth Advisors Inc.

B. Riley Wealth Advisors Inc. lowered its holdings in Agilent Technologies, Inc. (NYSE:A) by 32.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,570 shares of the medical research company’s stock after selling 1,711 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Agilent Technologies were worth $497,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in shares of Agilent Technologies by 3.2% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 2,421 shares of the medical research company’s stock valued at $337,000 after purchasing an additional 75 shares during the last quarter. Carmel Capital Partners LLC lifted its stake in Agilent Technologies by 1.2% during the fourth quarter. Carmel Capital Partners LLC now owns 6,709 shares of the medical research company’s stock valued at $933,000 after buying an additional 78 shares in the last quarter. Monumental Financial Group Inc. boosted its holdings in shares of Agilent Technologies by 0.9% in the fourth quarter. Monumental Financial Group Inc. now owns 9,493 shares of the medical research company’s stock worth $1,320,000 after buying an additional 89 shares during the period. Kepos Capital LP boosted its holdings in shares of Agilent Technologies by 3.5% in the third quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock worth $310,000 after buying an additional 93 shares during the period. Finally, Rosenberg Matthew Hamilton increased its position in shares of Agilent Technologies by 51.1% in the fourth quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after acquiring an additional 96 shares in the last quarter.

Agilent Technologies Stock Up 0.4 %

A opened at $133.25 on Monday. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. The business has a 50 day moving average price of $139.83 and a 200 day moving average price of $138.39. The firm has a market cap of $38.88 billion, a P/E ratio of 31.50, a price-to-earnings-growth ratio of 4.50 and a beta of 1.07.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.03. The business had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. Agilent Technologies’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.27 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 5.25 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd will be paid a $0.236 dividend. The ex-dividend date of this dividend is Tuesday, July 2nd. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.71%. Agilent Technologies’s payout ratio is presently 22.22%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Barclays decreased their price objective on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating for the company in a research note on Friday, May 31st. Jefferies Financial Group reiterated a “hold” rating and set a $135.00 price target (down previously from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. Evercore ISI reduced their price objective on Agilent Technologies from $145.00 to $126.00 and set an “in-line” rating for the company in a research note on Thursday, May 30th. Citigroup lowered their target price on Agilent Technologies from $145.00 to $135.00 and set a “neutral” rating on the stock in a research note on Thursday, May 30th. Finally, Robert W. Baird reduced their price target on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a research report on Thursday, May 30th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $136.50.

Insider Buying and Selling

In other news, SVP Dominique Grau sold 15,000 shares of the stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the sale, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at $6,595,494.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $130.00, for a total transaction of $254,540.00. Following the sale, the chief executive officer now directly owns 25,185 shares of the company’s stock, valued at $3,274,050. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Dominique Grau sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the transaction, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.